The myotonic dystrophy type 1 drug development pipeline: 2026 Edition.
Saved in:
| Title: | The myotonic dystrophy type 1 drug development pipeline: 2026 Edition. |
|---|---|
| Authors: | Ferchichi Y; Human Translational Genomics Group, University Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Av. Vicent Andrés Estellés, 19, Valencia 46100, Spain; INCLIVA Biomedical Research Institute, Av. Menendez Pelayo 4, Valencia 46010, Spain; Ciberer Isciii, Av. Monforte de Lemos 3-5, Madrid 28029, Spain., Natividad À; Human Translational Genomics Group, University Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Av. Vicent Andrés Estellés, 19, Valencia 46100, Spain; INCLIVA Biomedical Research Institute, Av. Menendez Pelayo 4, Valencia 46010, Spain; Ciberer Isciii, Av. Monforte de Lemos 3-5, Madrid 28029, Spain., Artero R; Human Translational Genomics Group, University Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Av. Vicent Andrés Estellés, 19, Valencia 46100, Spain; INCLIVA Biomedical Research Institute, Av. Menendez Pelayo 4, Valencia 46010, Spain; Ciberer Isciii, Av. Monforte de Lemos 3-5, Madrid 28029, Spain., López-Castel A; Human Translational Genomics Group, University Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Av. Vicent Andrés Estellés, 19, Valencia 46100, Spain; INCLIVA Biomedical Research Institute, Av. Menendez Pelayo 4, Valencia 46010, Spain; Ciberer Isciii, Av. Monforte de Lemos 3-5, Madrid 28029, Spain. Electronic address: arlocas@uv.es. |
| Source: | Drug discovery today [Drug Discov Today] 2026 May 27; Vol. 31 (4), pp. 104706. Date of Electronic Publication: 2026 May 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5832 (Electronic) Linking ISSN: 13596446 NLM ISO Abbreviation: Drug Discov Today Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42208802 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The myotonic dystrophy type 1 drug development pipeline: 2026 Edition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ferchichi+Y%22">Ferchichi Y</searchLink>; Human Translational Genomics Group, University Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Av. Vicent Andrés Estellés, 19, Valencia 46100, Spain; INCLIVA Biomedical Research Institute, Av. Menendez Pelayo 4, Valencia 46010, Spain; Ciberer Isciii, Av. Monforte de Lemos 3-5, Madrid 28029, Spain.<br /><searchLink fieldCode="AU" term="%22Natividad+À%22">Natividad À</searchLink>; Human Translational Genomics Group, University Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Av. Vicent Andrés Estellés, 19, Valencia 46100, Spain; INCLIVA Biomedical Research Institute, Av. Menendez Pelayo 4, Valencia 46010, Spain; Ciberer Isciii, Av. Monforte de Lemos 3-5, Madrid 28029, Spain.<br /><searchLink fieldCode="AU" term="%22Artero+R%22">Artero R</searchLink>; Human Translational Genomics Group, University Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Av. Vicent Andrés Estellés, 19, Valencia 46100, Spain; INCLIVA Biomedical Research Institute, Av. Menendez Pelayo 4, Valencia 46010, Spain; Ciberer Isciii, Av. Monforte de Lemos 3-5, Madrid 28029, Spain.<br /><searchLink fieldCode="AU" term="%22López-Castel+A%22">López-Castel A</searchLink>; Human Translational Genomics Group, University Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Av. Vicent Andrés Estellés, 19, Valencia 46100, Spain; INCLIVA Biomedical Research Institute, Av. Menendez Pelayo 4, Valencia 46010, Spain; Ciberer Isciii, Av. Monforte de Lemos 3-5, Madrid 28029, Spain. Electronic address: arlocas@uv.es. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229604391%22">Drug discovery today</searchLink> [Drug Discov Today] 2026 May 27; Vol. 31 (4), pp. 104706. <i>Date of Electronic Publication: </i>2026 May 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9604391 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-5832 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213596446%22">13596446 </searchLink><i>NLM ISO Abbreviation: </i>Drug Discov Today <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42208802 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.drudis.2026.104706 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 104706 Titles: – TitleFull: The myotonic dystrophy type 1 drug development pipeline: 2026 Edition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ferchichi Y – PersonEntity: Name: NameFull: Natividad À – PersonEntity: Name: NameFull: Artero R – PersonEntity: Name: NameFull: López-Castel A IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 05 Text: 2026 May 27 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1878-5832 Numbering: – Type: volume Value: 31 – Type: issue Value: 4 Titles: – TitleFull: Drug discovery today Type: main |
| ResultId | 1 |
